| Literature DB >> 35423835 |
Dénes Szepesi Kovács1,2, Imre Hajdu1,2, Gergely Mészáros3,4, Lucia Wittner3, Domokos Meszéna3,4, Estilla Zsófia Tóth3,5, Zita Hegedűs6, Ivan Ranđelović6, József Tóvári6, Tímea Szabó7, Bence Szilágyi2, Mátyás Milen7, György Miklós Keserű1,2, Péter Ábrányi-Balogh1,2.
Abstract
The first representatives of the new fluorescent boro-β-carboline family were synthesized by the insertion of the difluoroboranyl group into the oxaza or diaza core. The resulting compounds showed good photophysical properties with fine Stokes-shifts in the range of 38-85 nm with blue and green emission. The energetics of the excitation states and molecular orbitals of two members were investigated by quantum chemical computations suggesting effects for the improved properties of diazaborinino-carbolines over oxazaborolo-carbolines. These properties nominated this chemotype as a new fluorophore for the development of fluorescent probes. As an example, diazaborinino-carbolines were used for the specific labeling of anti-Her2 antibody trastuzumab. The fluorescent conjugate showed a high fluorophore-antibody ratio and was confirmed as a useful tool for labeling and confocal microscopy imaging of tumour cells in vitro together with the ex vivo two-photon microscopy imaging of tumour slices. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35423835 PMCID: PMC8697281 DOI: 10.1039/d1ra02132j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1Biologically active and fluorescent compounds together with the aims of this work.[18–20]
Results of the synthesis of 1-(ethyl-1-ol)-β-carbolines (14), 15 ketones and 11 boro-β-carbolines
|
| ||||||
|---|---|---|---|---|---|---|
| Entry | Compound |
|
| 14 [%] | 15 [%] | 11 [%] |
| 1 | a | H | H | 77 | 70 | 82 |
| 2 | b | H | CH3 | 66 | 57 | 55 |
| 3 | c | H | Ph | 73 | 46 | — |
| 4 | d | H | 4-MeO-C6H4 | 35 | 52 | — |
| 5 | e | CH3 | H | 74 | 46 | 79 |
| 6 | f | CH3 | CH3 | 72 | 50 | 92 |
Isolated yields.
Yields with Dess–Martin periodinane.
Scheme 1Synthesis of oxazaborolo-carbolines (11).
Scheme 2Synthesis of diazaborinino-carbolines (12a–d).
Results of the synthesis of compounds 16a–d and 12a–d
| Entry | Compound |
|
| 16 [%] | 12 [%] |
|---|---|---|---|---|---|
| 1 | a | H | Im | 49 | 27 |
| 2 | b | H | Bim | 33 | 95 |
| 3 | c | COOMe | Bim | 67 | 63 |
| 4 | d | COOMe | Py | 15 | 74 |
Isolated yields.
Imidazole-2-yl.
Benzimidazole-2y-l.
Pyridine-2-yl.
Method B was applied.
Photophysical properties of oxazaborolo- and diazaborinino carbolines
| # | Compound |
|
|
|
|
| Δ |
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 11a | H | H | 375 | 378 | 450 | 75 | 506 | 0.49 | 248 |
| 2 | 11b | H | Me | 379 | 376 | 417 | 38 | 11 700 | 0.21 | 2460 |
| 3 | 11e | Me | H | 377 | 377 | 445 | 68 | 5150 | 0.0062 | 32 |
| 4 | 11f | Me | Me | 363 | 378 | 435 | 72 | 11 700 | 0.27 | 3160 |
| 5 | 12a | H | Im | 396 | 380 | 472 | 76 | 3750 | 0.40 | 1500 |
| 6 | 12b | H | Bim | 414 | 398 | 484 | 70 | 8860 | 0.45 | 3990 |
| 7 | 12c | COOMe | Bim | 405 | 393 | 465 | 60 | 9320 | 0.47 | 4380 |
| 8 | 12d | COOMe | Py | 407 | 404 | 489 | 85 | 23 500 | 0.27 | 6360 |
Imidazole-2-yl.
Benzimidazole-2y-l.
Pyridine-2-yl.
Fig. 2Schematic representation of the excitation and fluorescence with computed energetics together with the visualized molecular orbitals, atomic charges and electrostatic potential (ESP) surface for 11f and 12d. On the ESP surface charges change from red (negative) to blue (positive). The atomic charges change from red (negative) to green (positive).
Fig. 3Solvent effect on excitation and emission spectra of 11f oxazaborolo-carboline (a) and 12d diazaborinino-carboline (b).
Fig. 4Photostability of 11f and 12d carbolines.
Scheme 3(a) Synthesis of 12f dye with NHS ester group and antibody-fluorophore conjugate 18; (b) SDS-PAGE in non-reducing gel: (I) molecular weight protein marker (kDa), (II) trastuzumab, (III) 18, (IV) 18 under 366 nm light.
Fig. 5(A) Confocal images showing the BK-bound trastuzumab antibody (18) on MDA-MB-231 (left), OVCAR-8 (middle) and SKOV-3 (right) tumour sections. Note that only the cell membrane is marked, therefore cells appear as circles (white arrows). Scale bar: 100 μm. (B) Two-photon microscopy images of living tumour tissue incubated with the BK-bound trastuzumab antibody. Infrared image (IR, left) shows the tumour tissue, fluorescent image (middle) demonstrates that cells of the SKOV-3 tumours bound the antibody. Note that the fluorescent image is coloured artificially. Connective tissue surrounding the groups of tumour cells are autofluorescent. Scale bar: 50 μm.